会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 172. 发明授权
    • Immuno-suppressive agent
    • 免疫抑制剂
    • US5380834A
    • 1995-01-10
    • US11463
    • 1993-01-27
    • Sadanori MizukoshiFuminori KatoMasamitsu TsukamotoKenji Kon
    • Sadanori MizukoshiFuminori KatoMasamitsu TsukamotoKenji Kon
    • C07H3/08C07H3/10C07H7/02C07H11/00C07H13/04C07H13/06C07H13/08C07H13/12C07H15/04C07H15/18C07H15/207C07D309/32
    • C07H13/04C07H11/00C07H13/06C07H13/08C07H13/12C07H15/04C07H15/18C07H15/207C07H3/08C07H3/10C07H7/02
    • An immuno-suppressive agent containing, as an effective component, an, enopyranose derivative of the following formula (I) or its salt: ##STR1## wherein R.sup.1 is a hydrogen atom, alkyl which may be substituted, alkenyl, alkynyl, --OSO.sub.2 R.sup.7, a halogen atom, --OCOR.sup.7, --NHCOR.sup.8, alkoxy, phenyl which may be substituted or a saccharose residue, R.sup.2 is a hydrogen atom or alkyl, R.sup.3 is a hydrogen atom or a halogen atom, R.sup.4 is a hydrogen atom, --COR.sup.9, silyl which may be substituted or alkyl which may be substituted, one of R.sup.5 and R.sup.6 is hydroxyl, alkoxy which may be substituted, a saccharose residue, cycloalkyloxy which may be substituted or --OCOR.sup.10 and the other is a hydrogen atom or alkyl which may be substituted, or R.sup.4 and R.sup.5 together form a single bond, while R.sup.6 is a hydrogen atom or alkyl which may be substituted, each of R.sup.7, R.sup.9 and R.sup.10 is alkyl or phenyl which may be substituted, R.sup.8 is alkyl, phenyl which may be substituted or benzyloxy, X is a hydrogen atom, alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted, pyridyl which may be substituted, furanyl which may be substituted, thienyl which may be substituted, formyl, --COR.sup.11, --C(W.sup.1)W.sup.2 R.sup.11 or --SO.sub.2 R.sup.11, R.sup.11 is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted, or a polycyclic heterocycle group which may be substituted, W.sup.1 is an oxygen atom or a sulfur atom, W.sup.2 is an oxygen atom, a sulfur atom or --NH--, Y is a hydrogen atom, alkyl which may be substituted, alkenyl which may be substituted or alkynyl which may be substituted.
    • 含有作为有效成分的下式(I)的吡喃葡萄糖衍生物或其盐的免疫抑制剂:其中R1是氢原子,可被取代的烷基,烯基,炔基, -OSO 2 R 7,卤素原子,-OCOR 7,-NHCOR 8,烷氧基,可被取代的苯基或蔗糖残基,R 2是氢原子或烷基,R 3是氢原子或卤原子,R 4是氢原子, COR9,可被取代的甲硅烷基或可被取代的烷基,R 5和R 6之一是羟基,可以被取代的烷氧基,可以被取代的蔗糖残基,可被取代的环烷基氧基或-OCOR 10,另一个是氢原子或烷基 或R 4和R 5一起形成单键,而R 6为氢原子或可被取代的烷基,R 7,R 9和R 10各自为可被取代的烷基或苯基,R 8为烷基, 取代或苄氧基,X为氢原子,可被取代的烷基,烯基 可被取代的炔基,可被取代的环烷基,可被取代的苯基,可被取代的吡啶基,可被取代的呋喃基,可被取代的噻吩基,甲酰基,-COR 11,-C( W1)W2R11或-SO2R11,R11是可以被取代的链状烃基,可以被取代的单环烃基,可以被取代的多环烃基,可以被取代的单环杂环基或多环杂环基 其可以被取代,W1是氧原子或硫原子,W2是氧原子,硫原子或-NH-,Y是氢原子,可以被取代的烷基,可被取代的链烯基或可以被取代的炔基, 被替代。
    • 175. 发明公开
    • 고요산혈증 또는 통풍에 유효한 섬쑥부쟁이 추출물, 이의 분획물 및 이로부터 분리된 활성화합물
    • ASTER GLEHNI提取物,分离物或化合物,用于治疗或预防高血压或GOUT
    • KR1020150135037A
    • 2015-12-02
    • KR1020140121178
    • 2014-09-12
    • 한국과학기술연구원
    • 김형자진창배손민정이용섭육창수이재열
    • A61K36/28A23L1/30A61K31/7028
    • A61K36/28A23L33/105A23V2002/00A23V2200/30A61K31/7028A61K2236/39C07H15/18C07H15/207
    • 본발명은고요산혈증또는통풍의치료, 예방및 개선에유효한섬쑥부쟁이 () 추출물, 이의분획물및 이로부터분리된활성화합물에관한것이다. 본발명의섬쑥부쟁이 () 추출물, 이의분획물, 그리고상기분획물로부터분리된활성화합물로서 6'--카페오일엠플롭시시오노사이드 (6'--caffeoylampelopsisionoside), 6'--카페오일로세오사이드 (6'--caffeoylroseoside), 6'--카페오일손츄이오노사이드씨 (6'--caffeoylsonchuinoside C), 6'--카페오일디히드로시린진 (6'--caffeoyldihydrosyringin), 글레노사이드 (glehnoside)는요산의생성억제효능및 농도강하효능이우수하다. 따라서본 발명의섬쑥부쟁이 () 추출물, 이의분획물, 그리고상기분획물로부터분리된활성화합물은요산의농도증가로인하여유발되는질환으로서고요산혈증또는통풍의치료, 예방및 개선이필요한의약품, 건강식품등의활성성분으로유용하게사용될수 있다.
    • 本发明涉及Aster glehni提取物,其一部分和从其中分离的活性化合物,其有效治疗,预防和改善高尿酸血症或痛风。 本发明提供了Aster glehni提取物,其分数和从其分离的活性化合物,其中6'-O-咖啡酰罂粟碱苷,6'-O-咖啡酰基甙,6'-O-咖啡酰胆碱酯C,6'-O-咖啡酰二氢肉豆蔻苷,6 'O-咖啡酰二氢肉豆蔻酸和格列本苷具有抑制尿酸生成和滴加浓度的功效。 因此,根据本发明的Aster glehni提取物及其分离的活性化合物可有效地用作治疗,预防和改善高尿酸血症或痛风所需的药物,保健食品等的活性成分, 这是由尿酸浓度增加引起的疾病。